The week in health tech, explained in plain English.Get the free newsletter →
October 26, 2026

Takeaways from the most recent news in the technology and policies shaping healthcare.

Hospitals

500 Merrimack Health Workers Join 1199SEIU Union

About 500 employees at Merrimack Health Lawrence (Mass.) Hospital have joined 1199SEIU United Healthcare Workers East, according to a July 24 union news release shared with Becker's Hospital Review. The new unit covers a broad mix of clinical and support staff, including nurse's aides, phlebotomists, housekeepers, transport workers, pharmacy technicians, and radiology aides. The workers began organizing in 2025.

The move adds to a wave of union activity across U.S. hospitals, where staffing shortages, workload, and pay have pushed both bedside clinicians and support workers to organize. 1199SEIU is one of the largest healthcare unions in the country, and its expansion into a broad service-and-technical unit signals that organizing is reaching beyond nurses into the roles that keep hospitals running.

In practice, the vote sets up contract negotiations over wages, staffing levels, and working conditions. For hospital leaders, a newly organized workforce means added labor costs and a formal bargaining process, at a time when many systems are already under financial and staffing pressure.

More in Hospitals

Hospitals

Visitor Fatally Shot at HCA Missouri Hospital; Patient Charged

A visitor was fatally shot at HCA Healthcare's Centerpoint Medical Center in Missouri, and patient James Lawson faces second-degree murder charges.

Why it matters: Violence inside hospitals is driving systems to rethink weapons screening and access control to protect patients, staff, and visitors.

Hospitals

Pay Dispute Puts Illinois Hospital's Trauma Status at Risk

An Illinois hospital's level 2 trauma designation is under state review after its anesthesia group suspended services over a missed payment.

Why it matters: A single vendor contract breakdown can strip a hospital of its trauma status and leave a community without nearby emergency surgical care.

Hospitals

Merck-Moderna mRNA Cancer Vaccine Cuts Melanoma Risk 42%

Merck and Moderna's personalized mRNA cancer vaccine cut melanoma recurrence or death by 42% in a phase 3 trial when paired with Keytruda immunotherapy.

Why it matters: A successful phase 3 readout signals that personalized mRNA cancer vaccines are nearing clinical reality for high-risk cancer patients.